Update to safety information in PREGNYL package insert

MSD Pharma (Singapore) Pte Ltd, would like to communicate an update to the safety information in the Singapore package insert of PREGNYL with immediate effect. The current package insert supplied with the product would not contain these changes until the new batch of supply expected in Q1 2018. The specific changes are reflected in Section 4.3 under Contraindications and Section 4.4 under Special warnings and precautions for use. These include addition of a new contraindication “Abnormal (not menstrual) vaginal bleeding without a known/diagnosed cause”, as well as updated or additional information to the warnings. Please refer to the letter for details.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.